By Greg Hazley
The California Institute for Regenerative Medicine, a state-backed, $3 billion embryonic stem cell research institution, has renewed its relationship with Fleishman-Hillard, following a competitive RFP process.
Don Gibbons, chief communications officer for the CIRM, said seven proposals were received after an RFP went out in late May.
F-H worked with the CIRM for the past two years. The institute, the first of its kind in the country, sought pitches to handle traditional PR, social media and other outreach on an 11-month contract capped at $125K/year.
Forging ties with thought leaders, patient advocates and the public are all on the agenda.
The CIRM was created by statewide voter referendum in November 2004 with the passage of a $3B bond issue, following the Golden State’s creation of the first law to permit such research in 2002.
|